Covid: in Italy 2,140 patients treated with antibodies, ‘safe and effective’ virologists

Rome, April 19 (beraking latest news Salute) – There are 2,140 Covid positive patients treated in Italy with monoclonal antibody-based therapy, according to the latest monitoring of the Aifa registry on monoclonal antibodies. “We at Spallanzani have treated about a hundred people out of a total of 300 in therapy in Lazio, from our experience the tolerability profile is safe as well as the effectiveness since only 10% of patients saw a progression of the disease after the treatment”. This was explained by Andrea Antinori, director of Uoc Viral Immunodeficiencies of the Inmi Spallanzani in Rome, in his speech at the event ‘Waiting for CameraeSanitatis – Fight against Covid: vaccines and monoclonal antibodies’, promoted by the collaboration between the Parliamentary Intergroup Science & Health and Sics publisher.

Antinori’s position was also shared by Claudio Mastroianni, director of Infectious Diseases of the Policlinico Umberto I in Rome, who underlined in his speech that “the results of the antibodies are very satisfactory”.

“In the observation of the patients, which we follow after the infusion with follow-up and examinations, we have not observed any significant adverse events: a few more lines of fever but we cannot say if it is connected with the therapy since these patients have the Covid – added Antinori – From our experience the tolerability profile appears safe, our target was a population “over 55”, with a risk of progression of Sars-CoV-2, dialysis, immunosuppressed, with uncompensated diabetes or large obese. Only 10% had a progression of the disease, while in 90% of cases the antibodies proved effective in blocking it in the first states “.